Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term GH Replacement in CHF
NCT01576861Phase 2Completed
- Sponsor
- University of Naples Federico II
- Start
- Jan 2007
- Primary completion
- Mar 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of somatotropin in chronic heart failure (CHF) and growth hormone deficiency (GHD) (2 arms), sponsored by University of Naples Federico II. Primary endpoints: Peak Oxygen Consumption at 48 months and Side effects at 48 months. Started Jan 2007; status: completed.
02
Drugs
somatotropin
03
Conditions
chronic heart failure (CHF)growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT01576861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01576861.